Kanada - anglų - Health Canada

mylan pharmaceuticals ulc - ziprasidone (ziprasidone hydrochloride monohydrate) - capsule - 20mg - ziprasidone (ziprasidone hydrochloride monohydrate) 20mg - atypical antipsychotics

Kanada - anglų - Health Canada

mylan pharmaceuticals ulc - ziprasidone (ziprasidone hydrochloride monohydrate) - capsule - 40mg - ziprasidone (ziprasidone hydrochloride monohydrate) 40mg - atypical antipsychotics

Kanada - anglų - Health Canada

mylan pharmaceuticals ulc - ziprasidone (ziprasidone hydrochloride monohydrate) - capsule - 60mg - ziprasidone (ziprasidone hydrochloride monohydrate) 60mg - atypical antipsychotics

Kanada - anglų - Health Canada

mylan pharmaceuticals ulc - ziprasidone (ziprasidone hydrochloride monohydrate) - capsule - 80mg - ziprasidone (ziprasidone hydrochloride monohydrate) 80mg - atypical antipsychotics

Kanada - anglų - Health Canada

genmed a division of pfizer canada ulc - ziprasidone (ziprasidone hydrochloride monohydrate) - capsule - 20mg - ziprasidone (ziprasidone hydrochloride monohydrate) 20mg - atypical antipsychotics

Kanada - anglų - Health Canada

genmed a division of pfizer canada ulc - ziprasidone (ziprasidone hydrochloride monohydrate) - capsule - 40mg - ziprasidone (ziprasidone hydrochloride monohydrate) 40mg - atypical antipsychotics

Kanada - anglų - Health Canada

genmed a division of pfizer canada ulc - ziprasidone (ziprasidone hydrochloride monohydrate) - capsule - 60mg - ziprasidone (ziprasidone hydrochloride monohydrate) 60mg - atypical antipsychotics

Kanada - anglų - Health Canada

genmed a division of pfizer canada ulc - ziprasidone (ziprasidone hydrochloride monohydrate) - capsule - 80mg - ziprasidone (ziprasidone hydrochloride monohydrate) 80mg - atypical antipsychotics

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

lake erie medical dba quality care products llc - fluoxetine hydrochloride (unii: i9w7n6b1kj) (fluoxetine - unii:01k63sup8d) - fluoxetine 10 mg - fluoxetine is indicated for the acute and maintenance treatment of major depressive disorder in adult patients and in pediatric patients aged 8 to 18 years [see clinical studies (14.1) ]. the usefulness of the drug in adult and pediatric patients receiving fluoxetine for extended periods should periodically be re-evaluated [see dosage and administration (2.1) ]. fluoxetine is indicated for the acute and maintenance treatment of obsessions and compulsions in adult patients and in pediatric patients aged 7 to 17 years with obsessive compulsive disorder (ocd) [see clinical studies (14.2) ]. the effectiveness of fluoxetine in long-term use, i.e., for more than 13 weeks, has not been systematically evaluated in placebo-controlled trials. therefore, the physician who elects to use fluoxetine for extended periods should periodically re-evaluate the long-term usefulness of the drug for the individual patient [see dosage and administration (2.2) ]. fluoxetine is indicated for the acute and maintenance treatment of bin

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

teva pharmaceuticals usa, inc. - fluoxetine hydrochloride (unii: i9w7n6b1kj) (fluoxetine - unii:01k63sup8d) - fluoxetine 20 mg in 5 ml